Matthews, GM, Lefebure, M, Doyle, MA, Shortt, J, Ellul, J, Chesi, M, Banks, KM, Vidacs, E, Faulkner, D, Atadja, P, Bergsagel, PL and Johnstone, RW (2013) Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma - art. no. e798. CELL DEATH & DISEASE.

Item Type:	Article
Additional Information:	pubid: 178 nvp_institute: NIBR contributor_address: Peter MacCallum Canc Ctr, Gene Regulat Lab, East Melbourne, Vic 3002, Australia, Univ Melbourne, Sir Peter MacCallum Dept Oncol, East Melbourne, Vic, Australia geoff.matthews@petermac.org; Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic 3002, Australia ; Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ USA, Mayo Clin Arizona, Scottsdale, AZ USA ; Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic 3002, Australia ; Novartis Inst Biomed Res, Cambridge, MA USA ; Peter MacCallum Canc Ctr, Gene Regulat Lab, East Melbourne, Vic 3002, Australia; Univ Melbourne, Sir Peter MacCallum Dept Oncol, East Melbourne, Vic, Australia; Matthews, G M; Peter MacCallum Canc Ctr, Gene Regulat Lab, St Andrews Pl, East Melbourne, Vic 3002, Australia
Date Deposited:	13 Oct 2015 13:12
Last Modified:	13 Oct 2015 13:12
URI:	https://oak.novartis.com/id/eprint/22000